The 6.75% coupon and 90% issue price indicate high credit risk. With $626M market cap and $115M debt, leverage increases significantly. Monitor for potential stock price pressure as conversion shares may be hedged or sold. The greenshoe option adds further overhang. Watch for any pipeline updates that could offset dilution concerns.
Price Chart
Executive Summary
Ocugen priced $115M of 6.75% convertible senior notes due 2034 at a 90% discount to par, with net proceeds of ~$99.5M ($112.6M if greenshoe exercised). The offering is dilutive (conversion price ~$2.68, 45% premium to $1.85 close) and will repay $32.7M of Avenue Capital debt, with the rest for general corporate purposes. Given the company's $626M market cap, this is a material capital raise that increases leverage and dilution risk.
Key Financial Metrics
Key Facts
- $115M aggregate principal of 6.75% convertible senior notes due 2034 priced at 90% of par
- Initial purchaser has 13-day option for additional $15M of notes
- Net proceeds ~$99.5M (~$112.6M if greenshoe exercised)
- ~$32.7M of net proceeds to repay Avenue Capital loan; remainder for general corporate purposes
- Conversion price ~$2.68 per share (45% premium to $1.85 close on May 4, 2026)
- Initial conversion rate: 372.7866 shares per $1,000 principal
- Notes mature May 15, 2034; interest 6.75% semi-annual; callable after May 15, 2029 under stock price conditions
- Holders can put notes at par on May 15, 2032 or upon fundamental change
- Conversion may be settled in cash, stock, or combination at Ocugen's election; cash settlement until reserved share effective date
- Offering to close May 7, 2026
Financial Impact
$115M principal at 90% price = $103.5M gross; net ~$99.5M; $32.7M debt repayment; remaining ~$66.8M for corporate purposes. Dilution: up to ~42.9M shares if fully converted (at $2.68 conversion price), representing ~6.9% of current 626M market cap at $1.85/share.
Risk Factors
- Dilution from conversion of notes (~42.9M shares at $2.68) could pressure stock price
- High 6.75% interest cost adds ~$7.8M annual interest expense
- 90% issue price implies weak demand and credit concerns
- Cash settlement until reserved share effective date may limit immediate dilution but creates future overhang
- General corporate purposes use of proceeds lacks specific catalyst
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3287656 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | Press Release | $1.33 $1.05 | ▼ −21.05% | ▼ −22.23% | $1.02 (−22.93%) |
Jul 13, 2026 11w ago | 8-K | $1.41 $1.31 | ▼ −7.09% | ▼ −10.28% | $1.02 (−27.30%) |
Jun 11, 2026 16w ago | 8-K | $1.21 $1.47 | ▲ +21.49% | ▲ +19.71% | $1.02 (−15.29%) |
Jun 11, 2026 16w ago | Institutional Cluster | $1.22 $1.47 | ▲ +20.49% | ▲ +18.60% | $1.02 (−15.98%) |
May 5, 2026 21w ago | 8-K | $1.49 $1.34 | ▼ −10.07% | ▼ −15.02% | $1.02 (−31.21%) |
May 5, 2026 21w ago | Press Release | $1.49 $1.34 | ▼ −10.07% | ▼ −15.02% | $1.02 (−31.21%) |
May 5, 2026 21w ago | Press Release | $1.49 $1.34 | ▲ +10.07% | ▲ +15.02% | $1.02 (+31.21%) |
May 4, 2026 21w ago | 8-K | $1.49 $1.34 | ▼ −10.07% | ▼ −15.02% | $1.02 (−31.21%) |
Apr 29, 2026 22w ago | Press Release | $1.68 $1.38 | ▼ −17.86% | ▼ −23.32% | $1.02 (−38.99%) |
Mar 24, 2026 27w ago | Press Release | $1.92 $1.68 | ▼ −12.50% | ▼ −21.40% | $1.02 (−46.61%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access